Analysis of N- and O-linked protein glycosylation in children with Prader-Willi syndrome

Journal of Intellectual Disability Research

Volumn 54, Issue 10, 2010, Pages 929-937

  Munce, T ^a,b   Heussler, H S ^a,b   Bowling, F G ^a  

^a MATER CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Mass spectrometry; Prader Willi syndrome; Protein glycosylation

Indexed keywords

APOLIPOPROTEIN C3; ASPARAGINE LINKED OLIGOSACCHARIDE; TRANSFERRIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANCY; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; SCHOOL CHILD; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; APOLIPOPROTEIN C-III; CHILD; CHILD, PRESCHOOL; GENOTYPE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; INFANT; INFANT, NEWBORN; ISOELECTRIC FOCUSING; N-ACETYLNEURAMINIC ACID; PHENOTYPE; PRADER-WILLI SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFERRIN; YOUNG ADULT;

EID: 77956792736     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2010.01323.x     Document Type: Article

References (27)

1. Barone R, Sturiale L, Garozzo D. Mass spectrmetry in the characterization of human genetic glycosylation defects. Mass Spectrometry Reviews 2009, 28:517-42.
2. Bittle D C, Kibiryeva N, Butler M G. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behaviour outcomes in Prader-Willi Syndrome. Pediatrics 2006, 118:e1276-e1283.
3. Bondarenko P V, Cockrill S L, Watkins L K, Cruzado I D, Macfarlane R D. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. Journal of Lipid Research 1999, 40:543-55.
4. Burd L, Vesely B, Martsolf J, Kerbeshian J. Prevalance study of Prader-Willi syndrome in North Dakota. American Journal of Medical Genetics 1990, 37:97-9.
5. Butler M G, Bittel D C, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioural differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 2004, 113:565-73.
6. Cassidy S B. Prader-Willi syndrome. Journal of Medical Genetics 1997, 34:917-23.
7. Chai J H, Locke D P, Greally J M, Knoll J H, Ohta T, Dunai J. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. American Journal of Human Genetics 2003, 73:898-925.
8. Chen C, Visootsak J, Dills S, Graham J. Prader-Willi syndrome: an update and review for the primary paediatrician. Clinical Pediatrics 2007, 46:580-91.
9. Dykens E M. Are jigsaw puzzle skills 'spared' in persons with Prader-Willi syndrome? Journal of Child Psychology and Psychiatry, and Allied Disciplines 2002, 43:343-52.
10. Ehara H, Ohno K, Takeshita K. Frequency of the Prader-Willi syndrome in the San-in district, Japan. Brain & Development 1995, 17:324-6.
11. Feigerlova E, Diene G, Conte-Auriol F, Molinas C, Gennero I, Salles J P. Hyperprolinemia precedes obesity in Prader-Willi syndrome. The Journal of Clinical Endocrinology and Metabolism 2008, 93:2800-5.
12. Haqq A M, Muehlbauer M, Svetkey L P, Newgard C B, Purnell J Q, Grambow S C. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clinical Endocrinology 2007, 67:944-51.
13. Holland A J, Whittington J E, Butler J, Webb T, Boer H, Clarke D. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Psychological Medicine 2003, 33:141-53.
14. Holm V A, Cassidy S B, Butler M G, Hanchett J M, Greenwag L R, Whitman B Y. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91:398-402.
15. Huibregtse J M, Scheffner M, Beaudenon S, Howley P. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:5249.
16. Jong M, Carey A, Caldwell K, Lau M, Handel M, Driscoll D. Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Human Molecular Genetics 1999, 8:795-803.
17. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1960, 227:680.
18. Lorick K L, Jensen J P, Fang S, Ong A M, Hatakeyama S, Weissman A M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:11364-9.
19. Mann C J, Troussard A A, Yen F T, Hannouche N, Najib J, Fruchart J-C. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. The Journal of Biological Chemistry 1997, 272:31348-54.
20. Ooi E M, Barrett P H, Chan D C, Watts G F. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clinical Science (Lond) 2008, 114:611-24.
21. Sahoo T, del Gaudio D, German J R, Shinawi M, Peters S U, Person R E. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nature Genetics 2008, 40:719-21.
22. Satomi Y, Shimonishi Y, Hase T, Takao T. Site-specific carbohydrate profiling of human transferrin by nano-flow liquid chromatography/electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 2004, 18:2983-8.
23. Smith A, Egan J, Ridley G, Haan E, Montgomery P, Williams K. Birth prevalence of Prader-Willi syndrome in Australia. Archives of Disease in Childhood 2003, 88:263-4.
24. Varela M C, Kok F, Setian N, Kim C A, Koiffmann C P. Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients. Clinical Genetics 2005, 67:47-52.
25. Wopereis S, Grunewald S, Huijben K, Morava E, Mollicone R, van Engelen B. Transferrin and apolipoprotein C-III Isofocusing are complementary in the diagnosis of N-and O-glycan biosynthesis defects. Clinical Chemistry 2007, 53:180-7.
26. Wopereis S, Grunewald S, Morava E, Penzien J M, Briones P, Garcia-Silva T. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clinical Chemistry 2003, 49:1839-45.
27. Wu M Y, Tsai T F, Beaudet A L. Deficiency of Rbbp1/Arid4a and Rbbp111/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain. Genes Dev 2006, 20(20):2859-70. 2006 Oct 15